Chong Kun Dang Pharmaceutical

NCT01241032

Phase I Study to Investigate the Alcohol Interaction of DA8159

NCT00956306

A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function

NCT01297036

Pharmacokinetic Comparisons of Two Donepezil Formulations

NCT00969787

DWP05195 in Healthy Adult Male Volunteers

NCT00961025

A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects

NCT01016626

Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet

NCT01019941

Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer

NCT01005160

Drug Interaction Between CKD-501 and Metformin

NCT01231997

Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients

NCT01028859

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

NCT01071720

The Effect of Food on the Pharmacokinetic Characteristics of CKD-501

NCT01094834

A Multiple Dose Study of DWP05195 in Healthy Adult Subjects

NCT01094847

Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine

NCT01104948

A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects

NCT01133431

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea

NCT01851512

A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

NCT01820715

A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain

NCT01156779

Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

NCT01246193

CKD-828(80/2.5mg) Pharmacokinetic Study

NCT01270984

Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects

NCT01663038

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination

NCT01340131

CKD-828 (40/5mg) Pharmacokinetic Study

NCT01330563

Drug-drug Interaction Study (CKD-501, Ketoconazole)

NCT01341392

Drug-drug Interaction Study(CKD-501, Amlodipine)

NCT01352689

CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

NCT01341249

A Study to Compare the Pharmacokinetic Profiles of DW224aa and DW224a

NCT01356043

CKD-828 Drug Interaction Study (S-amlodipine)

NCT01356017

CKD-828 Drug Interaction Study (Telmisartan)

NCT01369472

Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule

NCT01340248

A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers

NCT01367080

A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg

NCT01415466

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

NCT01423526

A Single Dose Study of DWP10292 in Healthy Male Subjects

NCT01496261

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial

NCT01493856

A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

NCT01522586

Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031

NCT01653314

Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers

NCT01651858

Nurigra Chewable Tablet in Healthy Adult Male Volunteers

NCT01580371

Safety and Pharmacokinetic Profile of CKD-581

NCT01560325

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

NCT01654601

A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg

NCT01776047

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

NCT01635686

Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

NCT01684605

Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers

NCT01685671

Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers

NCT01819870

Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg

NCT01842230

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

NCT01842256

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

NCT01941199

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects

NCT01929213

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration

NCT01928563

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine

NCT01942551

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

NCT01964365

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers

NCT02002611

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

NCT02004327

The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

NCT02058472

Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers

NCT02047175

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

NCT02066207

CKD-337 Drug Interaction Study

NCT02005744

A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function

NCT02007941

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

NCT02332044

Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

NCT02064556

CKD-330 Drug-Drug Interaction Study (Amlodipine)

NCT02089399

Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

NCT02212795

Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin

NCT02064621

CKD-330 Drug-Drug Interaction Study (Candesartan)

NCT02156544

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

NCT02186496

Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)

NCT02212756

Pharmacokinetic Profiles of Metformin With DW1029M

NCT02212769

the Pharmacokinetic Profiles of Losartan With DW1029M

NCT02212782

the Pharmacokinetic Profiles of Linagliptin With DW1029M

NCT02247505

CKD-397 Drug-drug Interaction Study (B)

NCT02247518

CKD-397 Drug-drug Interaction Study (A)

NCT02250833

CKD-828 (80/5mg) Pharmacokinetic Study

NCT02288338

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

NCT02300467

NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors

NCT02336854

Tacrobell tab_Phase1_PK

NCT02352311

Safety and Pharmacokinetic Characteristics of DKF-313

NCT02369302

Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers

NCT02358824

CKD-828 (80/5mg) Pharmacokinetic Study

NCT02385032

Comparative Bioavailability Study of UDCA

NCT02422030

CKD-337(2) Drug-drug Interaction Study

NCT02801526

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A

NCT02811731

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B

NCT02622685

A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

NCT02484482

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

NCT02502721

A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

NCT02461004

CKD-391 Pharmacokinetic Study

NCT02565368

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers

NCT02501200

CKD-391 Pharmacokinetic Study Phase I

NCT02548286

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

NCT02627027

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

NCT02631954

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

NCT02561884

A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers

NCT02589457

Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet

NCT02623868

Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.

NCT02648854

Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

NCT02645890

Study to Compare the Safety and Pharmacokinetics of CKD-397

NCT02615782

A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects

NCT02704559

Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects

NCT02651753

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

NCT02665832

Study of DWJ1351 in Healthy Male Volunteers

NCT02685774

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

NCT02695004

Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

NCT03016494

Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

NCT02757144

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

NCT02753504

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

NCT02824874

CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

NCT02827890

CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

NCT03233932

CKD-841 Pharmacokinetic/Pharmacodynamic Study

NCT02854748

Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin

NCT02894541

Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519

NCT02916901

Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers

NCT03050177

Bioequivalence Study of Gefitinib Tablets Under Fed Conditions

NCT03050164

Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions

NCT02947139

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers

NCT02952547

Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

NCT02952755

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers

NCT03017950

Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

NCT03005223

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers

NCT03016520

Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

NCT03051841

CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma

NCT03034486

The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930

NCT03029533

Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer

NCT03210649

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

NCT03282825

Clinical Study of Decitabine and Paclitaxel Combination Therapy

NCT03127046

Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

NCT03175835

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

NCT03150316

CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma

NCT03346187

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

NCT03512808

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

NCT03211143

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

NCT03512821

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

NCT03382756

A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

NCT03364985

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers

NCT03753477

Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

NCT03444402

A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

NCT03487562

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

NCT03569579

CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)

NCT03713892

CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects

NCT03671941

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers

NCT03573622

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

NCT03574285

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions

NCT03558425

A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects

NCT03601910

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg

NCT03616392

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

NCT03659149

Pharmacokinetics and Safety Profile of CKD-333

NCT03609606

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

NCT03646799

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults

NCT03726866

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

NCT03793985

Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

NCT03748212

Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers

NCT03574415

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean

NCT03738449

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition

NCT03849261

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults

NCT03849339

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition

NCT03802162

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

NCT03849495

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults

NCT03868072

"Study to Evaluate the Bioequivalence of Pfizer Korea Inc. XELJANZ 5Mg Tablet in Healthy Volunteers"

NCT03849287

Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults

NCT03858725

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers

NCT03947489

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

NCT03947528

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions

NCT03887858

"Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. Harnal-D in Healthy Volunteers"

NCT03887871

"Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. Harnal-D in Healthy Volunteers After Meal"

NCT03920579

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

NCT03848637

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

NCT04272502

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

NCT04003441

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers

NCT04278391

"Pharmacokinetics and Safety Between DWJ1421 and DWC201903 in Healthy Male Volunteers"

NCT04019743

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

NCT04156685

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

NCT04064073

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)

NCT04035538

A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

NCT04083846

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)

NCT04083872

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

NCT04075643

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

NCT04354987

Compare the Pharmacokinetics and Safety of CKD-391

NCT04167267

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)

NCT04185805

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)

NCT04159961

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

NCT04746287

Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects

NCT04221360

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

NCT04221399

Type 2 Diabetes Patients With Renal Impairment

NCT04223895

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers

NCT04304547

Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

NCT04246190

A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396

NCT04258865

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348

NCT04322032

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389

NCT04260438

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects

NCT04343547

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults

NCT04334213

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150

NCT04667975

The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy

NCT04393597

Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults

NCT04431687

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

NCT04490434

Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs

NCT04488900

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

NCT04478097

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

NCT04477369

Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers

NCT04524052

To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19

NCT04328766

Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

NCT05749380

Pharmacokinetics and Safety of AmBisome and DKF-5122

NCT04703374

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

NCT04587206

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

NCT04592835

To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003

NCT04651881

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

NCT04678388

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

NCT04611932

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers

NCT04673695

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344

NCT04535856

Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients

NCT04673682

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

NCT04749173

To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.

NCT04627207

A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers

NCT04541485

To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)

NCT04660370

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

NCT04673864

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

NCT04827472

Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

NCT04706286

Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

NCT04694989

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)

NCT04676893

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects

NCT04782505

Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

NCT04819932

Pharmacokinetics and Safety of DWJ1451 in Healthy Adults

NCT04767815

To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers

NCT04768673

A Study to Investigate the PK and Safety of CKD-393

NCT04810676

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

NCT04830930

A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers

NCT04867200

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

NCT04805606

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

NCT04840745

The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1

NCT05414591

Pharmacokinetics and Safety Following Administration of DWP16001

NCT04869800

Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg

NCT04883658

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

NCT04906785

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

NCT04906798

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

NCT04888728

To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

NCT04952506

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

NCT04888715

To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

NCT04987970

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

NCT05149274

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

NCT05108038

A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects

NCT05089279

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

NCT05403281

A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

NCT05113693

Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393

NCT05321732

The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults

NCT06508645

Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers

NCT05189288

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects

NCT05207761

Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930

NCT05832697

An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

NCT05207176

Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities

NCT05192356

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

NCT05238948

CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects

NCT05245084

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg

NCT05304845

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

NCT05192395

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

NCT05347576

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

NCT05335044

Study to Evaluate the Safety and Pharmacokinetics of CKD-331

NCT05274880

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

NCT05465668

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

NCT05452525

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

NCT05874167

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

NCT05816681

Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

NCT05526742

A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects

NCT05500898

Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults

NCT05540912

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

NCT06399055

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions

NCT06399068

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions

NCT05574374

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

NCT05552495

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions

NCT05549401

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

NCT05544214

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects

NCT05812404

Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

NCT05607589

The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects

NCT05571813

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

NCT05587699

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

NCT05634447

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

NCT05874180

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

NCT05737771

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

NCT05673369

Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition

NCT05699070

Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects